1. Home
  2. BWMX vs ALLO Comparison

BWMX vs ALLO Comparison

Compare BWMX & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWMX
  • ALLO
  • Stock Information
  • Founded
  • BWMX 1995
  • ALLO 2017
  • Country
  • BWMX Mexico
  • ALLO United States
  • Employees
  • BWMX N/A
  • ALLO N/A
  • Industry
  • BWMX Catalog/Specialty Distribution
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BWMX Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • BWMX Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • BWMX 429.1M
  • ALLO 427.7M
  • IPO Year
  • BWMX N/A
  • ALLO 2018
  • Fundamental
  • Price
  • BWMX $12.22
  • ALLO $2.17
  • Analyst Decision
  • BWMX Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • BWMX 1
  • ALLO 10
  • Target Price
  • BWMX $22.50
  • ALLO $10.06
  • AVG Volume (30 Days)
  • BWMX 22.4K
  • ALLO 9.8M
  • Earning Date
  • BWMX 02-27-2025
  • ALLO 03-13-2025
  • Dividend Yield
  • BWMX 11.97%
  • ALLO N/A
  • EPS Growth
  • BWMX N/A
  • ALLO N/A
  • EPS
  • BWMX 1.21
  • ALLO N/A
  • Revenue
  • BWMX $700,821,742.00
  • ALLO $43,000.00
  • Revenue This Year
  • BWMX $9.30
  • ALLO N/A
  • Revenue Next Year
  • BWMX $6.59
  • ALLO N/A
  • P/E Ratio
  • BWMX $10.04
  • ALLO N/A
  • Revenue Growth
  • BWMX 6.88
  • ALLO 26.47
  • 52 Week Low
  • BWMX $10.05
  • ALLO $1.32
  • 52 Week High
  • BWMX $21.28
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • BWMX 63.18
  • ALLO 55.14
  • Support Level
  • BWMX $12.00
  • ALLO $1.32
  • Resistance Level
  • BWMX $12.60
  • ALLO $3.78
  • Average True Range (ATR)
  • BWMX 0.41
  • ALLO 0.36
  • MACD
  • BWMX 0.17
  • ALLO 0.10
  • Stochastic Oscillator
  • BWMX 81.90
  • ALLO 34.55

About BWMX Betterware de Mexico S.A.P.I. de C.V.

Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: